Here’s Why Now Is a Good Time to Get Greedy With Canopy Growth (TSX:WEED) Stock!

Canopy Growth Corp (TSX:WEED)(NYSE:CGC) may have just put in a bottom with the first decent quarter in a long time!

| More on:
edit Cannabis leaves of a plant on a dark background

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

The cannabis trade dried up a long time ago. But that’s exactly why I think Canopy Growth (TSX:WEED)(NYSE:CGC), Canada’s top cannabis kingpin and the “safest” way to play the stomach-churning industry, is now worthy of your investment dollars. To make big money as an investor, you’ve got to be like Warren Buffett and be greedy while others are fearful (and vice versa!) and the rules still apply to the crazy, fast-moving world of marijuana!

Cannabis crashes (or corrections) are nothing new. If you sold on the last few meltdowns in Canopy, you lost out on a sharp rebound and multi-bagger gains that followed. While the recent sell-off is more violent, with Canopy and Aurora Cannabis stock plunging over 70% and 85%, respectively, from peak to trough, I think that in the grander scheme of things that the current downfall will be dwarfed by upward moves over the next decade and beyond.

While it’s impossible to tell if we’re near a bottom, Canopy’s latest results were encouraging — a sign that there’s still life (and opportunity) within the pot space, which most have already given up on.

Canopy soars on better-than-feared third-quarter numbers

Last week, Canopy pulled the curtain on results that weren’t as bad as what many were expecting, given the company has been making a habit of missing the mark with wider-than-expected losses. The stock popped 16% in a single trading session and could mark the start of a sustained rally back to all-time highs.

The third quarter was supposed to be the eighth consecutive miss, marking two straight years of quarterly misses, but Canopy pulled off the unthinkable with EPS losses of $0.35, beating the consensus estimate of an EPS loss of $0.49.

While the battle with the black market wages on in what I see as an eventual race to the bottom, Canopy still managed to grow net revenues by 62% quarter over quarter. That’s still incredible growth in an industry that I think still has plenty of gas left in the tank. With Canopy Growth stock currently trading at 1.9 times book and 26.3 times sales, I see the budding producer as a bargain compared to most other hyper-growth stocks out there with P/S multiples north of 40.

Gross margins crept higher thanks in part to higher-margin consumer product sales. And with more high-margin products (like edibles) that could prop margins up further as they become more widely available, I wouldn’t rule out continued margin expansion, even as the broader industry looks to sacrifice margins to gain business lost to the black market.

Management also expects to see gross margins jump to 40% over the near term, as a result of the “Cannabis 2.0” tailwind and inventory management initiatives to prevent future markdowns.

Profitability may seem like a pipe dream for Canopy, but I think it’s on the right track to sustainably moving into the green within five years. Management learned from its past mistakes and could evolve to become a leader in the space with Constellation Brands as its dance partner.

Further volatility is undoubtedly expected from Canopy (and the industry) moving forward, but if you’re able to buy and forget the roller-coaster ride of a stock, now may be an opportune time while shares remain cheap and out of the radar of the momentum-chasing speculators who’ve since moved on to greener pastures.

Stay hungry. Stay Foolish.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Joey Frenette has no position in any of the stocks mentioned. The Motley Fool recommends Constellation Brands.

More on Cannabis Stocks

Cannabis smoke
Cannabis Stocks

Canopy Growth Stock: Is Now a Good Time to Invest?

The road ahead is highly uncertain for Canopy Growth, as the stock is plagued with losses and seemingly unsurmountable industry…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

TLRY Stock: Should You Invest Now?

TLRY is a Canadian cannabis stock which is trading 91% below record highs. Let's see if you should own TLRY…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is Tilray Stock a Buy in February 2023?

Despite the volatile cannabis sector, Tilray could be a superb buy for long-term investors.

Read more »

Young woman sat at laptop by a window
Cannabis Stocks

Is SNDL Stock a Buy in February 2023?

SNDL is a beaten-down cannabis stock. While its revenue growth is exceptional, a weak balance sheet has driven stock prices…

Read more »

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »